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(three patients). Stem cell sources included BM (four patients),
PBPC (10 patients) and one cord blood transplant; related (6
patients) and unrelated (9 patients). Match grade was 6/6 for 13
transplants, 5/6 for one and 4/6 for the cord blood. GVHD
prophylaxis was standard dose cyclosporine or tacrolimus and
MMF, tapering after day 60. Median follow-up was seven months
(range 1.5-30 months). There were no WBC engraftment failures.
Neutrophil (ANC 	500/dl) engraftment occurred at a median of
13 days (range 10-48 days). Three patients had grade I-II acute
GVHD and one had chronic GVHD. One had grade III acute
GVHD. Relapse occurred in three patients and they received DLI
immunotherapy. Twelve patients survived to day 100 (80%). Four
were alive at one year and four others who are still alive have not
reached the one year mark. Four of the seven patients died with
residual/relapsing disease (26%) and three died with treatment
related toxicity (20%). Eight of 15 patients remain in follow-up.
We conclude that the application of ﬂudarabine, melphalan and
alemtuzumab conditioning regimens has been successful in these
high risk patients, with a low incidence of acute GVHD (27%), no
engraftment failures and a low incidence (20%) of relapsed disease.
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INFECTION-RELATED MORTALITY AFTER ALLOGENEIC HEMATOPOI-
ETIC CELL TRANSPLANTATION FROM HLA-MATCHED RELATED AND
UNRELATED DONORS
Yamasaki, S.1, Fukuda, T.1, Kim, S.-W.1, Mori, S.-I.1, Tanosaki, R.1,
Taniguchi, S.2, Takaue, Y.1 1. National Cancer Center Hospital, Tokyo,
Japan; 2. Toranomon Hospital, Tokyo, Japan.
Infection is a major cause of transplant-related morbidity and mor-
tality after allogeneic hematopoietic cell transplantation (HCT). To
clarify the importance of management of infectious complications
after allogeneic HCT, we retrospectively reviewed the medical
records of 185 adult patients with hematologic malignancies who
underwent allogeneic HCT at our center between 2000 and 2004.
The diagnoses included acute myeloid leukemia or myelodysplastic
syndrome (n  87), chronic myelogenous leukemia (n  20), acute
lymphoblastic leukemia (n  20), lymphoma (n  55), and other
hematologic malignancies (n  3). The conditioning regimen for
conventional stem cell transplantation (CST) was cyclophosphamide
plus 12 Gy total body irradiation (TBI) (n 60) or busulfan (n 44),
and that for reduced-intensity stem cell transplantation (RIST) was
ﬂudarabine plus busulfan with (n 18) or without (n 61) 4 GyTBI.
One-hundred-nine patients received G-CSF-mobilized peripheral
blood stem cells from anHLA-matched relative (R-PBSCT; CST 48,
RIST 61) and 76 patients received bone marrow from an HLA-
matched unrelated volunteer (U-BMT; CST 58, RIST 18). The
median age of the patients in the RIST group was older than that of
the CST group (54 years vs 38 years). Neutrophil engraftment was
faster in the R-PBSCT group than that in the U-BMT group (me-
dian; day 11 vs day 18) regardless of conditioning regimens. The
cumulative incidences of grades II to IV acute graft-versus-host dis-
ease (GVHD) in the R-PBSCT and U-BMT groups were 46% and
49%, respectively. Within 1 year of transplant, 11 (10%) of the 109
patients who underwent R-PBPCT and 25 (33%) of the 76 patients
who underwent U-BMT died of non-relapse causes. Non-relapse
mortality within 1 year after CST and RIST were 23% and 15%,
respectively. Among the 36 patients who died of non-relapse causes,
17 (47%) had grades III to IV acute GVHD and 13 (36%) had
infectious complications. In conclusion, our study showed that U-
BMT was associated with an increased risk of infection-related mor-
tality. Future study should focus on better management of infectious
complications and GVHD after HCT from an unrelated donor.
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ALLOGENEIC STEM CELL TRANSPLANTATION IN INFANTS. A SINGLE
INSTITUTION EXPERIENCE
Gonzalez-LLano, O., Cantu-Rodriguez, O.G., Mancias-Guerra, C.,
Gutierrez-Aguirre, C.H., Tovar-Martinez, C., Jaime-Perez, J.C.,
Gomez-Almaguer, D. Hospital Universitario U.A.N.L., Monterrey,
Nuevo Leon, Mexico.
Allogeneic stem cell transplantation (ASCT) is the treatment of
choice for a variety of hematologic and non hematologic diseases. The
ASCThave special implications when the patient involved is an infant.
We analyzed the results of ASCT in infants in our institution. From
1997 to 2004 every infant who was treated with an ASCT in our
hospital was included. A total of 6 infants were treated with an ASCT,
3 males and 3 females. One patient had acute lymphoblastic leukemia
(ALL), one osteopetrosis (OP) who underwent 2 ASCT, one severe
combined immunodeﬁciency syndrome (SCIDS) and 3 hemophago-
cytic lymphohistiocytosis (HL). In one patient the bone marrow was
the source of stem cells, in 3 patients it was peripheral blood, and in
2 patients the stem cells were obtained from unrelated cord blood
(one underwent 2 cord blood ASCT). Four patients had a related
matched stem cell transplant, and two patients had an unrelated
mismatched cord blood transplant with 5/6 matches. Reduced inten-
sity conditioning regimen was used in 5 ASCT, myeloablative in the
patient with HL done in 1997, and none in the patient with SCIDS.
Only the 2 ASCT achieved in the infant with OP did not engraft.
Graft versus host disease (GVHD) was present in 2 of the other 4
patients. Grade IV acute GVHD due to severe GI affectation in one
infant with HL who underwent cord blood transplantation occurred
and hepatic chronic GVHD in the HL patient transplanted in 1997
whose haematopoietic stem cell source was the bone marrow. Five
patients are alive. The girl who did not engraft after two ASCT has
osteopetrosis activity. Four patients: a girl with ALL, 2 boys with HL
and a boy with SCIDS are disease free survivors without GVHD 25,
16, 101, and 53 months after ASCT. A girl with HL died due to sepsis
and severe GI GVHD day 35 after transplant. In conclusion, we
found in this small number of patients that 5 out of 6 patients are alive
and 4 are disease free after a median of 48 months. We believe that
haematopoietic stem cell transplantation, specially using reduced in-
tensity conditioning regimen, can be safely used with good results in
the pediatric population.
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CHIMERISM AND T CELL RECEPTOR REPERTOIRE ANALYSIS AFTER
UNRELATED CORD BLOOD TRANSPLANTATION WITH A REDUCED-
INTENSITY CONDITIONING REGIMEN FOLLOWING AUTOLOGOUS
STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA
Toubai, T.1, Tanaka, J.1, Hirate, D.1, Ota, S.2, Sugita, J.1,
Miura, Y.1, Kato, N.1, Kondo, K.2, Iwao, N.1, Asaka, M.2,
Imamura, M.1 1. Department of Hematology and Oncology, Hokkaido
University Graduate School of Medicine, Sapporo, Hokkaido, Japan; 2.
Department of Gastroenterology and Hematology, Hokkaido University
Graduate School of Medicine, Sapporo, Hokkaido, Japan.
A 65-year-old Japanese male was diagnosed in October 2002 as
having multiple myeloma with Bence Jones kappa type, clinical
stage IIIA. His disease status reached partial remission after vin-
cristine, Adriamycin and dexamethasone (VAD) therapy. Thereaf-
ter, he received tandem transplantation, consisting of high-dose
chemotherapy with autologous stem cell transplantation (ASCT),
followed by unrelated cord blood transplantation (CBT) with a
reduced-intensity conditioning regimen, from which a graft-ver-
sus-host myeloma effect was anticipated. CBT with a reduced-
intensity conditioning regimen was performed in August 2003.
HLA mismatch between the patient and the CB donor was present
at two loci (B and DR). The conditioning regimen consisted of
ﬂudarabine, busulfan and total body irradiation (TBI). A total
nucleated CB cell dose of 2.45  107/kg body weight was infused
on day 0. Graft-versus-host disease (GVHD) prophylaxis had been
planned with cyclosporine A and short-term methotrexate. Neu-
trophil engraftment (	0.5  109/L) was obtained on day 46. We
analyzed in detail the chimerism status of PB subsets to predict
graft rejection. Although his white blood cell count (WBC) was
0.2 109/L on day 27, showing nearly complete donor chimerism.
He developed cytomegalovirus antigenemia, bacteremia, grade II
acute GVHD involving skin and liver, varicella-zoster virus infec-
tion, septic shock, hemorrhagic cystitis due to adenovirus, and
acute hepatitis B virus infection after CBT. We retrospectively
analyzed T cell receptor (TCR) repertoire diversity and found that
TCR repertoire diversity decreased continuously after CBT.
Therefore, low TCR repertoire diversity appears to be associated
with various infections due to immunodeﬁciency.
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